Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS.
After injuries that penetrate the mature brain or spinal cord, damaged axons initially show a growth response, but later their regeneration is aborted as a dense permanent scar is laid down within the core of the wound. Functional recovery from such injuries is poor and morbidity is severe, particularly for those patients with spinal cord damage. Clinically, no long term therapeutic treatments have been developed that might inhibit scarring and promote neuronal growth. Consequently, the prevalence of patients permanently disabled from head and spinal cord injury is high, estimated at more than 1:1000 of the population of North America (Office of Technology Assessment USA, 1990). Ann Logan and Martin Berry define the mechanisms that underlie the wound healing response in the CNS and discuss the rationale for the development of novel therapeutic strategies.
Logan
A
A
Department of Clinical Chemistry, University of Birmingham, Edgbaston, UK.
Berry
M
M
D000818:Animals; D002490:Central Nervous System / Q000293:injuries* / Q000503:physiopathology*; D016222:Fibroblast Growth Factor 2 / Q000502:physiology*; D006801:Humans; D016212:Transforming Growth Factor beta / Q000502:physiology*; D014945:Wound Healing / Q000502:physiology
D016212:Transforming Growth Factor beta; D016222:Fibroblast Growth Factor 2